Pancragen Peptide (20mg)
$94.97
Research-grade Pancragen tetrapeptide bioregulator for pancreatic cell studies. Lyophilized KEDW sequence supports metabolic research applications.
Pancragen Peptide Description
Pancragen peptide is a targeted bioregulator for pancreatic research applications. This tetrapeptide targets pancreatic cell function studies, including glucose metabolism and endocrine pathway investigations.
Research initiated by Khavinson reveals Pancragen’s selective effects on pancreatic function in laboratory settings. The peptide bioregulator benefits metabolic research protocols examining insulin pathways.
Each batch undergoes thorough testing to meet research standards. Lyophilized formulation maintains stability for pancreatic cell culture applications. Research use only.
Peptide Information
| Property | Value |
|---|---|
| Peptide Sequence | H-Lys-Glu-Asp-Trp-OH |
| Molecular Formula | C₂₆H₃₆N₆O₉ |
| Molecular Weight | 576.25 g/mol |
| PubChem CID | 68452887 |
Lyophilized Peptides:
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
Related products
Cartalax (20mg)
Cortagen (20mg)
Cortagen is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Pro (AEDP). It belongs to the family of “Khavinson peptides,” which are short bioregulatory peptides typically composed of 2 to 4 amino acids. These peptides are known for their ability to influence gene expression in a tissue-specific manner and have been studied for their potential therapeutic effects on aging, inflammation, and tissue repair.
